Topiramate for drug-resistant epilepsies.

  title={Topiramate for drug-resistant epilepsies.},
  author={Sai-ChingJ. Yeung and Colin D. Ferrie and Deborah G Murdoch-Eaton and John H Livingston},
  journal={European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society},
  volume={4 1},
Topiramate is a new anti-epileptic drug with proven efficacy against partial seizures in adults. A retrospective assessment of the use of topiramate in drug-resistant childhood epilepsy was undertaken. Thirty-four children (median age of 10 years; range 2-18 years) were treated for a median of 9 months (range 6-18 months). The starting dose was 0.25-2.0 mg… CONTINUE READING